CNBC's Angelica Peebles reports the latest news surrounding GLP-1 drugs. Got a confidential news tip? We want to hear from ...

The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit ...

Trump's executive order says babies born in the U.S. are not entitled to citizenship if their parents are illegal immigrants ...

Jeff deGraaf, chairman and head of technical research at Renaissance Macro Research, joins 'Money Movers' to discuss market ...

Jim Rossman, global head of shareholder advisory at Barclays, joins 'Money Movers' to discuss shareholder activism, the ...

Eli Lilly Chair & CEO Dave Ricks tells CNBC’s Angelica Peebles that with the approval of the company’s GLP-1 pill, ...

Jean-Marie Mognetti, co-founder and CEO at CoinShares, joins 'Money Movers' to discuss the company's Nasdaq debut, the state ...

Headquartered live on the floor of the New York Stock Exchange, we are there when the all-important opening bell rings every ...

The president's comments are the latest threat to America's allies after their reluctance to help reopen the Strait of Hormuz ...

Iran's Revolutionary Guard has warned a number of tech companies with Middle East operations that they'll be considered ...

Stocks rose on Wednesday, while oil prices declined to start the month, as hope grew that an end to the U.S.-Iran war was on ...

Daan Struyven, co-head of global commodities research at Goldman Sachs, joins 'Squawk Box' to discuss the state of energy ...